S&P 500   5,074.91 (+1.87%)
DOW   38,959.58 (+0.90%)
QQQ   437.03 (+2.68%)
AAPL   183.48 (+0.64%)
MSFT   409.40 (+1.80%)
META   487.37 (+4.13%)
GOOGL   143.45 (+0.63%)
AMZN   173.61 (+2.98%)
TSLA   196.12 (+0.69%)
NVDA   774.71 (+14.82%)
NIO   5.76 (-3.52%)
AMD   182.59 (+11.14%)
BABA   76.20 (+0.82%)
T   16.63 (-2.18%)
F   12.18 (+0.33%)
MU   85.89 (+5.40%)
CGC   3.42 (-0.58%)
GE   151.86 (+1.87%)
DIS   107.83 (+0.15%)
AMC   4.39 (-3.94%)
PFE   27.48 (-0.69%)
PYPL   58.28 (+1.39%)
XOM   105.20 (+0.33%)
S&P 500   5,074.91 (+1.87%)
DOW   38,959.58 (+0.90%)
QQQ   437.03 (+2.68%)
AAPL   183.48 (+0.64%)
MSFT   409.40 (+1.80%)
META   487.37 (+4.13%)
GOOGL   143.45 (+0.63%)
AMZN   173.61 (+2.98%)
TSLA   196.12 (+0.69%)
NVDA   774.71 (+14.82%)
NIO   5.76 (-3.52%)
AMD   182.59 (+11.14%)
BABA   76.20 (+0.82%)
T   16.63 (-2.18%)
F   12.18 (+0.33%)
MU   85.89 (+5.40%)
CGC   3.42 (-0.58%)
GE   151.86 (+1.87%)
DIS   107.83 (+0.15%)
AMC   4.39 (-3.94%)
PFE   27.48 (-0.69%)
PYPL   58.28 (+1.39%)
XOM   105.20 (+0.33%)
S&P 500   5,074.91 (+1.87%)
DOW   38,959.58 (+0.90%)
QQQ   437.03 (+2.68%)
AAPL   183.48 (+0.64%)
MSFT   409.40 (+1.80%)
META   487.37 (+4.13%)
GOOGL   143.45 (+0.63%)
AMZN   173.61 (+2.98%)
TSLA   196.12 (+0.69%)
NVDA   774.71 (+14.82%)
NIO   5.76 (-3.52%)
AMD   182.59 (+11.14%)
BABA   76.20 (+0.82%)
T   16.63 (-2.18%)
F   12.18 (+0.33%)
MU   85.89 (+5.40%)
CGC   3.42 (-0.58%)
GE   151.86 (+1.87%)
DIS   107.83 (+0.15%)
AMC   4.39 (-3.94%)
PFE   27.48 (-0.69%)
PYPL   58.28 (+1.39%)
XOM   105.20 (+0.33%)
S&P 500   5,074.91 (+1.87%)
DOW   38,959.58 (+0.90%)
QQQ   437.03 (+2.68%)
AAPL   183.48 (+0.64%)
MSFT   409.40 (+1.80%)
META   487.37 (+4.13%)
GOOGL   143.45 (+0.63%)
AMZN   173.61 (+2.98%)
TSLA   196.12 (+0.69%)
NVDA   774.71 (+14.82%)
NIO   5.76 (-3.52%)
AMD   182.59 (+11.14%)
BABA   76.20 (+0.82%)
T   16.63 (-2.18%)
F   12.18 (+0.33%)
MU   85.89 (+5.40%)
CGC   3.42 (-0.58%)
GE   151.86 (+1.87%)
DIS   107.83 (+0.15%)
AMC   4.39 (-3.94%)
PFE   27.48 (-0.69%)
PYPL   58.28 (+1.39%)
XOM   105.20 (+0.33%)
LON:GLB

Glanbia (GLB) Share Price, News & Analysis

GBX 15.66
+0.25 (+1.60%)
(As of 05:35 PM ET)
Today's Range
15.64
16
50-Day Range
14
16.30
52-Week Range
11.37
16.92
Volume
17,782 shs
Average Volume
59,883 shs
Market Capitalization
£41.50 million
P/E Ratio
17.21
Dividend Yield
217.16%
Price Target
N/A

GLB stock logo

About Glanbia Stock (LON:GLB)

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It also engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, weight management, and bioactive solutions businesses. It operates a portfolio of brands, including Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

GLB Stock Price History

GLB Stock News Headlines

Latest News for Coinbase Glb Stock (NASDAQ:COIN)
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Search U.S. News Best Global Universities
See More Headlines
Receive GLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Glanbia and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6,163
Year Founded
N/A

Profitability

Net Income
£271.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.84 billion
Cash Flow
GBX 114.12 per share
Book Value
GBX 766 per share

Miscellaneous

Free Float
N/A
Market Cap
£41.50 million
Optionable
Not Optionable
Beta
0.54
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Mark A. Garvey (Age 60)
    Group Finance Director & Executive Director
    Comp: $1.95M
  • Mr. Hugh McGuire Dip Finance (Age 52)
    M.Sc, CEO, Director & Chief Executive Officer of Glanbia Performance Nutrition
  • Mr. Liam Hennigan
    Group Secretary, Head of Investor Relations & Grp. Dir. of Strategic Planning and Investor Relations
  • Ms. Martha Kavanagh
    Head of Corporate Communications
  • Mr. Ian Doyle (Age 46)
    Chief Corporate Development Officer
  • Ms. Sue Sweem (Age 59)
    Chief Human Resources Officer
  • Mr. Michael Patten (Age 62)
    Chief ESG & Corporate Affairs Officer
  • Mr. Tom Tench (Age 53)
    Chief Operating Officer of Glanbia Nutritionals
  • Mr. Brian Phelan (Age 57)
    Chief Executive Officer of Glanbia Nutritionals
  • Mr. Jim Bergin (Age 61)
    Chief Executive of Glanbia Ingredients Ireland Limited














GLB Stock Analysis - Frequently Asked Questions

How have GLB shares performed in 2024?

Glanbia's stock was trading at GBX 14.30 at the start of the year. Since then, GLB shares have increased by 9.4% and is now trading at GBX 15.64.
View the best growth stocks for 2024 here
.

How often does Glanbia pay dividends? What is the dividend yield for Glanbia?

Glanbia announced a dividend on Wednesday, August 16th. Shareholders of record on Thursday, August 24th will be given a dividend of GBX 0.14 per share on Friday, October 6th. This represents a dividend yield of 1%. The ex-dividend date is Thursday, August 24th. The official announcement can be seen at this link.
Read our dividend analysis for GLB
.

Is Glanbia a good dividend stock?

Glanbia (LON:GLB) pays an annual dividend of GBX 34 per share and currently has a dividend yield of 2.11%. The dividend payout ratio is 3,736.26%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GLB.

What other stocks do shareholders of Glanbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), Kerry Group (KRYAY), Kimberly-Clark (KMB), Glanbia (GLAPY), Glanbia (GLAPF), Diageo (DEO), Dalata Hotel Group (DAL), Bank of Ireland Group (BIRG), Atalaya Mining (ATYM) and Amryt Pharma (AMYT).

How do I buy shares of Glanbia?

Shares of GLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:GLB) was last updated on 2/22/2024 by MarketBeat.com Staff